Phase 3
N=32
Evaluate Dental Plaque Benefit of a Preventive Treatment Gel
Dental Plaque
Bottom Line
View on ClinicalTrials.gov: NCT03546491 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Mean Turesky Modified Quigley-Hein Index at Day 4 — 1.83; 1.96 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- Preventive Gel (Drug); Marketed Control (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Procter and Gamble
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Turesky Modified Quigley-Hein Index at Day 4 |
1.83; 1.96 | — |
| SECONDARY Mean Turesky Modified Quigley-Hein Index at Baseline |
2.19; 2.22 | — |
| SECONDARY Digital Plaque Imaging |
8.14; 10.95 | — |
| SECONDARY Overall Baseline Mean Digital Plaque Imaging |
6.57; 7.29 | — |
Summary
The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.
Eligibility Criteria
Inclusion Criteria
- Provide written informed consent prior to participation and be given a signed copy of the informed consent form;
- Be 18 years of age or older;
- Agree not to participate in any other oral/dental product studies during the study;
- Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
- Agree to refrain from the use of any non-study oral hygiene products (subjects who are regular flossers will be allowed to floss during acclimation and wash-out periods);
- Agree to use an oral hygiene product that contains stannous fluoride;
- Agree to refrain from any form of non-specified oral hygiene during the treatment period, including the use of products such as floss, toothpicks for plaque removal, and chewing gum;
- Agree to refrain from any oral hygiene, eating and drinking after 11:00 PM the evening before plaque measurements on Day 0 and Day 4 of the treatment periods;
- Agree to return for all scheduled visits and follow study procedures;
- Possess a minimum of 20 natural teeth with scorable facial and lingual surfaces, of which at least 4 are molars; and,
- Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.
Exclusion Criteria:• Have a medical condition requiring pre-medication prior to dental procedures;
- Have taken antibiotics within 2 weeks of the acclimation period or anticipate taking antibiotics at any time during the study;
- Have a history of allergies or hypersensitivity to dyes or dentifrices that contain stannous fluoride;
- Have removable or orthodontic appliances which interfere with obtaining 20 gradable teeth;
- Have previously demonstrated an inability to comply with study visit requirements;
- Have rampant caries, open or untreated caries, severe gingivitis or advanced periodontitis requiring prompt treatment; or,
- Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study.
Data sourced from ClinicalTrials.gov (NCT03546491). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.